Back

Frailty is associated with adverse cardiovascular outcomes in type 2 myocardial infarction: a prospective registry study

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Predicting major adverse cardiovascular events and long-term outcomes after acute coronary syndrome Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Simran Piya

Royal Infirmary of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Timing of heart failure after ST-segment elevation myocardial infarction and its association with long-term mortality
Mr U. Islam (Copenhagen, DK)
Abstract
Presentation thumbnail
A machine learning-based risk prediction model for major adverse cardiovascular events within one year after discharge in patients with acute coronous syndrome
Professor T. Li (Beijing, CN)
Abstract
Presentation thumbnail
Obstructive sleep apnea, insulin resistance and long-term cardiovascular outcomes in acute coronary syndrome
Doctor F. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Time-dependent survival benefit of late PCI in stable STEMI: a propensity-weighted analysis of the 12–48 hour window
Doctor M. Bergami (Bologna, IT)
Abstract
Presentation thumbnail
Temporal trends in primary ventricular fibrillation in the STEMI code era: a 15-year registry. Analysis of prevalence, acute-phase and long-term mortality
Doctor C. Garcia-Garcia (Barcelona, ES)
Abstract

Access the full session

Session thumbnail
Predicting major adverse cardiovascular events and long-term outcomes after acute coronary syndrome

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of clinical frailty scale on short and long term outcome in patients with acute coronary syndrome
8 March 2024
thumbnail
Congress Presentation
Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
31 August 2019
thumbnail
Webinar
The HFA Journal Club: navigating frailty in heart failure treatment decisions - from trials to tailored care
1 October 2025
thumbnail
Congress Presentation
Cardiovascular outcomes of HFpEF patients after cardiac rehabilitation
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources